BioSpace News Archive

HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced that the National Institute of Health and Care Excellence (NICE) has renewed its support for the use of its AI-powered HeartFlow® FFRct Analysis to fight coronary heart disease (CHD), one of the leading causes of death in the UK.

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the launching of a new research program for the development of a Melanoma antitumor targeting medicine

University of Miami integrates Movendo Technology’s robotic system hunova© into baseline screening and physical rehabilitation of their student-athletes.

Results of a multicenter trial recently published in Anesthesiology, the official peer-reviewed journal of the American Society of Anesthesiologists, demonstrated significant reductions in postoperative opioid use and pain following percutaneous peripheral nerve stimulation (PNS) compared to placebo.

Dosing of the first patient in a phase 3 clinical trial of ZYESAMI (aviptadil acetate) was announced by the National Institutes of Health (NIH) last week. The trial, designated as ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 (TESICO) (www.clinicaltrials.gov NCT04843761), will study ZYESAMI to treat severely ill COVID-19 patients

This natural biological approach to crop protection underscores the “E” in ESG - Environmental, Social, and Governance.

The company plans to expand its businesses with the rapid testing to its clients.

Stryker (NYSE:SYK) will participate in the Bank of America Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021. Spencer Stiles, Group President, Orthopaedics & Spine, Robert Cohen, President, Digital, Robotics and Enabling Technologies and Preston Wells, Vice President, Investor Relations will represent the Company in a virtual presentation scheduled for 4:15 p.m. Eastern Time.

Helping improve patient outcomes by identifying and removing barriers to their care is just one reason AllianceRx Walgreens Prime and Highmark Inc. have joined forces to launch a social determinants of health pilot outreach program.

t. The exercise price of the Debenture Warrants issued as part of the Debenture Units remains at $0.55 per Common Share.